Additionally, the combination of Rg3 and cisplatin increases cisplatin sensitivity and enhances its therapeutic effect on tumors by downregulation of HIF-1α expression and inhibiting tumor cell EMT in hypoxic lung cancer cells (96). This evidence concerns the gene HIF1A and lung carcinoma.